Cy5.5-DTPA-galactosyl-dextran: A fluorescent probe for in vivo measurement of receptor biochemistry

Nuclear Medicine and Biology

Volumn 32, Issue 7, 2005, Pages 687-693

  Vera, David R ^a   Hall, David J ^a   Hoh, Carl K ^a   Gallant, Pascal ^b   McIntosh, Laura M ^b   Mattrey, Robert F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ART Advanced Research Technologies Inc   (Canada)

Author keywords

Optical imaging; Radiopharmaceutical; Receptor binding

Indexed keywords

DEXTRAN; GALACTOSE; INDOCYANINE GREEN; PENTETIC ACID;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; KINETICS; MOLECULAR MODEL; MOLECULAR PROBE; PLASMA CLEARANCE; RABBIT; RECEPTOR BINDING;

EID: 27144538873     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2005.04.003     Document Type: Review

References (42)

1. R. Weissleder, and M. Rudin Molecular imaging in drug discovery and development Nat Rev 2 2003 123 128
2. W.C. Eckelman Sensitivity of new radiopharmaceuticals Nucl Med Biol 25 1998 169 173
3. D.R. Vera, and W.C. Eckelman Receptor 1980 and Receptor 2000: twenty years of progress in receptor-binding radiotracers [Editorial] Nucl Med Biol 28 2001 475 476
4. N. Kokudo, D.R. Vera, and M. Makuuchi Clinical application of TcGSA Nucl Med Biol 30 2003 845 849
5. R.C. Stadalnik, M. Kudo, W.C. Eckelman, and D.R. Vera In vivo functional imaging using receptor-binding radiopharmaceuticals: technetium-99m-galactosyl- neoglycoalbumin as a model Invest Radiol 28 1993 64 70
6. D.J. Hall, J.C. Hebden, and D.T. Delpy Imaging very-low contrast object in breast like scattering media with a time-resolved method Appl Opt 36 1997 7270 7276
7. 99mTc]DTPA-mannosyl- dextran J Nucl Med 42 2001 951 959
8. D.R. Vera, R.C. Stadalnik, and K.A. Krohn [Tc-99m]galactosyl- neoglycoalbumin: preparation and preclinical studies J Nucl Med 26 1985 1157 1167
9. R.B. Mujumdar, S.R. Mujumdar, C.M. Grant, and A.S. Waggoner Cyanine-labeling reagents: sulfobenzindocyanine succinimidyl esters Bioconjug Chem 7 1996 356 362
10. M. Dubios, K.A. Gilles, J.K. Hamilton, P.A. Rebers, and J. Smith Colorimetric method for determination of sugars and related substances Anal Chem 28 1956 350 356
11. 99mTc]DTPA-mannosyl-dextran Nucl Med Biol 30 2003 457 464
12. W.N. Kelly, and R.D. Ice Pharmaceutical quality of technetium-99m sulfur colloid Am J Hosp Pharm 30 1973 817 820
13. D.R. Vera, K.A. Krohn, R.C. Stadalnik, and P.O. Scheibe [Tc-99m]galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes Radiology 151 1984 191 196
14. 99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity Nucl Med Biol 18 1991 663 666
15. R.C. Stadalnik, D.R. Vera, E.S. Woodle, W.L. Trudeau, B.A. Porter, and R.E. Ward Technetium-99m NGA functional hepatic imaging: preliminary clinical experience J Nucl Med 26 1985 1233 1242
16. 99mTc]galactosyl-neoglycoalbumin J Nucl Med 31 1991 1169 1176
17. S.D. Colquhoun, C.A. Connelly, and D.R. Vera Portal-systemic shunts reduce asialoglycoprotein receptor density in rats J Nucl Med 42 2001 110 116
18. R. Kuwana, and E.M. Sevick-Muraca Fluorescence lifetime spectroscopy for pH sensing in scattering media Anal Chem 75 2003 4325 4329
19. R. Weissleder, and V. Ntziachristos Shedding light onto live molecular targets Nat Med 9 2003 123 128
20. V. Ntziachristos, and B. Chance Breast imaging technology: probing physiology and molecular function using optical imaging-application to breast cancer Breast Cancer Res 3 2001 41 46
21. A. Becker, B. Riefke, B. Ebert, U. Sukowski, H. Rinneberg, and W. Semmler Macromolecular contrast agents for optical imaging of tumors: comparison of indotricarbocyanine-labeled human serum albumin and transferrin Photochem Photobiol 72 2000 234 241
22. K. Licha, B. Riefke, V. Ntziachristos, A. Becker, B. Chance, and W. Semmler Hydrophilic cyanine dyes as contrast agents for near-infrared tumor imaging: synthesis, photophysical properties and spectroscopic in vivo characterization Photochem Photobiol 72 2000 392 398
23. J.S. Reynolds, T.L. Troy, R. Mayer, A.B. Thompson, D.J. Waters, and K. Cornell Imaging of spontaneous canine mammary tumor using fluorescent contrast agents Photochem Photobiol 70 1999 87 94
24. V. Ntziachristos, A.G. Yodh, M. Schall, and B. Chance Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement Proc Natl Acad Sci U S A 97 2000 2767 2772
25. M.M. Haglund, D.W. Hochman, A.M. Spence, and M.S. Berger Enhanced optical imaging of rat gliomas and tumor margins Neurosurgery 35 1994 930 939
26. M. Gurfinkel, A.B. Thompson, W. Ralston, T.L. Troy, A.L. Moore, and T.A. Moore Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study Photochem Photobiol 72 2000 94 102
27. S. Achilefu, R.B. Dorshow, J.E. Bugaj, and R. Rajagopalan Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging Invest Radiol 35 2000 479 485
28. A. Becker, C. Hessenius, K. Licha, B. Ebert, U. Sukowski, and W. Semmler Receptor-targeted optical imaging of tumor with near-infrared fluorescent ligands Nat Biotechnol 19 2001 327 331
29. J.E. Bugaj, S. Achilefu, R.B. Dorshow, and R. Rajagopalan Novel fluorescent contrast agents for optical imaging of in vivo binding, and in vivo tumors based on a receptor-targeted dye-peptide conjugate platform J Biomed Opt 6 2001 122 133
30. S. Achilefu, H.N. Jimenez, R.B. Dorshow, J.E. Bugaj, E.G. Webb, and R.R. Wilhelm Synthesis, in vitro binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents J Med Chem 45 2002 2003 2015
31. M.D. Kennedy, K.N. Jallad, D.H. Hompson, D. Ben-Amotz, and P.S. Low Optical imaging of metastatic tumor using a folate-targeted fluorescent probe J Biomed Opt 8 2003 636 641
32. W.K. Moon, Y. Lin, T. O'Loughlin, Y. Tang, D.E. Kim, and R. Weissleder Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate Bioconjug Chem 14 2003 539 545
33. A. Petrovsky, E.A. Schellenberger, L. Josephson, R. Weissleder, and A. Bogdanov Jr Near-infrared fluorescent imaging of apoptosis Cancer Res 63 2003 489 496
34. E.A. Schellenberger, A. Bogdanov Jr, A. Petrovsky, V. Ntziachristos, R. Weissleder, and L. Josephson Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy Neoplasia 5 2003 187 192
35. F.A. Jaffer, C.H. Tung, R.E. Gerszten, and R. Weissleder In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe Arterioscler Thromb Vasc Biol 22 2002 1929 1935
36. R. Weissleder, C.H. Tung, U. Mahmood, and A. Bogdanov Jr In vivo imaging of tumors with protease-activated near-infrared fluorescent probes Nat Biotechnol 17 1999 375 378
37. V. Ntziachristos, C. Bremer, C.H. Tung, and R. Weissleder Imaging cathepsin B up-regulation in HT-1080 tumor models using fluorescence-mediated molecular tomography (FMT) Acad Radiol 9 Suppl 2 2002 S323 S325
38. C.H. Tung, S. Bredow, U. Mahmood, and R. Weissleder Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging Bioconjug Chem 10 1999 892 896
39. C. Bremer, C.H. Tung, and R. Weissleder In vivo molecular target assessment of matrix metalloproteinase inhibition Nat Biotechnol 7 2001 743 748
40. T. Jiang, E.S. Olson, Q.T. Nguyen, M. Roy, P.A. Jennings, and R.Y. Tsien Tumor imaging by means of proteolytic activation of cell-penetrating peptides Proc Natl Acad Sci U S A 101 2004 17867 17872
41. 99mTc-GSA, a new agent for functional imaging of the liver Jap J Nucl Med 28 1991 1321 1331
42. D.R. Vera, P.O. Scheibe, K.A. Krohn, W.L. Trudeau, and R.C. Stadalnik Goodness-of-fit and local identifiability of a receptor-binding radiopharmacokinetic system IEEE Trans Biomed Eng BME-39 1992 356 367